These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8161672)

  • 21. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
    Osteyee JL; Banner W
    Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine.
    Netzer P; Eschenmoser K; Halter F; Inauen W
    Aliment Pharmacol Ther; 1999 Mar; 13(3):407-12. PubMed ID: 10102975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of automatic computerised pump to maintain constant intragastric pH.
    Hannan A; Chesner I; Merki HS; Mann S; Walt RP
    Gut; 1990 Nov; 31(11):1246-9. PubMed ID: 2253907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidine.
    Merki HS; Halter F; Wilder-Smith CH
    Gastroenterology; 1993 Sep; 105(3):748-54. PubMed ID: 8103027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses.
    Wilder-Smith CH; Halter F; Häcki W; Merki HS
    Br J Clin Pharmacol; 1992 May; 33(5):487-93. PubMed ID: 1524960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The timing of evening meal and ranitidine administration--effects on patterns of 24 hour intragastric acidity.
    Orr WC; Finn AL; Allen M; Robinson MG; Wilson T
    Aliment Pharmacol Ther; 1988 Dec; 2(6):541-9. PubMed ID: 2979277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single dose ranitidine: influence of the time of administration on gastric acidity in normal subjects and in patients with duodenal ulcer.
    Coppens JP; Warzee P; Schapira M; Fiasse R; Dive C
    Gastroenterol Clin Biol; 1988; 12(6-7):537-41. PubMed ID: 3417080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intragastric pH monitoring during antisecretory therapy in patient with gastrointestinal bleeding.
    Fiorucci S; Clausi GC; Farinelli M; Santucci L; Pelli MA; Morelli A
    Am J Gastroenterol; 1989 Nov; 84(11):1416-20. PubMed ID: 2816875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circadian differences in pharmacological blockade of meal-stimulated gastric acid secretion.
    Sanders SW; Moore JG; Day GM; Tolman KG
    Aliment Pharmacol Ther; 1992 Apr; 6(2):187-93. PubMed ID: 1600040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective comparison of the effects of placebo, ranitidine and highly selective vagotomy on 24 h ambulatory intragastric pH in patients with duodenal ulcer.
    Rogers MJ; Holmfield JH; Primrose JN; Gledhill T; Johnston D
    Br J Surg; 1988 Oct; 75(10):961-5. PubMed ID: 3219542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of an evening dose of regular and effervescent formulations of ranitidine or cimetidine on intragastric pH in healthy volunteers.
    Smout AJ; Jonkman JH; Peeters PA; De Bruin H
    Aliment Pharmacol Ther; 1995 Feb; 9(1):51-6. PubMed ID: 7766744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study.
    Baghaie AA; Mojtahedzadeh M; Levine RL; Fromm RE; Guntupalli KK; Opekun AR
    Crit Care Med; 1995 Apr; 23(4):687-91. PubMed ID: 7712759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?
    Merki HS; Wilder-Smith CH
    Gastroenterology; 1994 Jan; 106(1):60-4. PubMed ID: 8276209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty-four-hour intragastric acidity in duodenal ulcer patients during dosing with placebo, and 150 mg ranitidine twice or four times daily.
    Howden CW; Tsai HH; Reid JL
    Aliment Pharmacol Ther; 1989 Jun; 3(3):253-8. PubMed ID: 2520620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacodynamics of ranitidine in critically ill children.
    Lugo RA; Harrison AM; Cash J; Sweeley J; Vernon DD
    Crit Care Med; 2001 Apr; 29(4):759-64. PubMed ID: 11373465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamics of bolus famotidine versus infused cimetidine, ranitidine, and famotidine.
    Amsden GW; Goss TF; Harrison NJ; D'Andrea DT; Schentag JJ
    J Clin Pharmacol; 1994 Dec; 34(12):1191-8. PubMed ID: 7738215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.
    Mathôt RA; Geus WP
    Clin Pharmacol Ther; 1999 Aug; 66(2):140-51. PubMed ID: 10460068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control and variability of gastric pH in critically ill children.
    Gedeit RG; Weigle CG; Havens PL; Werlin SL
    Crit Care Med; 1993 Dec; 21(12):1850-5. PubMed ID: 8252889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
    Bachmann K; Sullivan TJ; Jauregui L
    J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.